In Chapter 2 titled "Seeking efficiency or price gouging? Evidence from pharmaceutical mergers," we show that pharmaceutical mergers are a response to ex-ante c
While innovation and growth can be promoted internally through focus on research and development (R&D), many firms find acquisition from external sources to be